Therapeutic potential of histamine H3 receptor agonists and antagonists
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 19 (5) , 177-184
- https://doi.org/10.1016/s0165-6147(98)01201-2
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Involvement of histamine in the control of the waking statePublished by Elsevier ,2002
- Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in miceLife Sciences, 1997
- Histamine and SeizuresCNS Drugs, 1996
- Histamine Receptor and its Regulation of Energy MetabolismObesity Research, 1995
- Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in miceLife Sciences, 1995
- Histaminergic Modulation of Hippocampal Acetylcholine Release In VivoJournal of Neurochemistry, 1994
- The behavioral effects of serotonin synthesis inhibition and quisqualic acid induced lesions of the nucleus basalis magnocellularis in ratsGeneral Pharmacology: The Vascular System, 1993
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Inhibitory effects of histamine on the release of serotonin and noradrenaline from rat brain slicesNeurochemistry International, 1991
- Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell-deficient W/Wv miceLife Sciences, 1991